Strength
12.5 mg/.25g
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802036862
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Last Updated
4/22/2026
Active Ingredients
IMIQUIMODApproval Type
Generic (ANDA)
FDA Application
ANDA078837On Market Since
11/9/2010
Pharmacological Classes
Increased Cytokine Activity
Increased Cytokine Production
Interferon Inducers